AKT1 and neoplasm: In the tumor xenografts, immunohistochemistry staining demonstrated that TAX treatment decreased the number of Ki67-positive cells and reduced the expression of c-Myc, cyclin D1, p-AKT and FGFR2 (Fig. 4d, e).